Celgene Corp (NASDAQ:CELG)

68.68
Delayed Data
As of 4:15pm ET
 -1.40 / -2.00%
Today’s Change
66.62
Today|||52-Week Range
110.81
-34.19%
Year-to-Date

Today’s Trading

Previous close70.08
Today’s open70.00
Day’s range67.23 - 70.00
Volume6,723,772
Average volume (3 months)5,448,298
Market cap$47.2B
Data as of 4:15pm ET, 12/10/2018

Growth & Valuation

Earnings growth (last year)+46.69%
Earnings growth (this year)+18.08%
Earnings growth (next 5 years)+20.75%
Revenue growth (last year)+17.40%
P/E ratio17.5
Price/Sales6.58
Price/Book7.41

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.83+0.94%
VRTXVertex Pharmaceutica...+1.57+0.91%
AGNAllergan-0.04-0.03%
SHPGShire-2.63-1.52%
Data as of 4:03pm ET, 12/10/2018

Financials

Next reporting dateJanuary 24, 2019
EPS forecast (this quarter)$2.32
Annual revenue (last year)$12.8B
Annual profit (last year)$2.9B
Net profit margin22.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
COO
Mark J. Alles
Chief Financial Officer &
Executive Vice President
David V. Elkins
Corporate headquarters
Summit, New Jersey

Forecasts